Beam Therapeutics, Inc. (BEAM)
24.09
+0.62
(+2.64%)
USD |
NASDAQ |
Oct 19, 14:45
Beam Therapeutics Cash from Operations (Annual) : -345.10M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -345.10M |
| December 31, 2024 | -347.25M |
| December 31, 2023 | -149.20M |
| December 31, 2022 | 22.53M |
| December 31, 2021 | -66.27M |
| Date | Value |
|---|---|
| December 31, 2020 | -95.74M |
| December 31, 2019 | -72.00M |
| December 31, 2018 | -20.30M |
| December 31, 2017 | -2.707M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Intellia Therapeutics, Inc. | -394.74M |
| Twist Bioscience Corp. | -47.63M |
| Prime Medicine, Inc. | -162.56M |
| Sarepta Therapeutics, Inc. | -222.54M |
| Q32 Bio, Inc. | -33.54M |